Cynthia Clayton

Cynthia Clayton is a seasoned professional in biotechnology communications and investor relations, boasting a strong track record of collaborating with both publicly traded and privately held companies as well as venture capital firms.

She holds a strong educational background having studied at the University of Hartford.

Cynthia Clayton has held prominent roles in various organizations, notably serving as the Vice President of Communications & Investor Relations at Third Rock Ventures. Prior to this, she also led the Communications and Investor Relations department at Third Rock Ventures. In the past, she occupied key positions such as Vice President of Investor Relations and Corporate Communications at Alnylam Pharmaceuticals, Senior Director of Investor Relations and Corporate Communications at Alnylam Pharmaceuticals, Director of Investor Relations and Corporate Communications at Synta Pharmaceuticals, and Senior Manager of Investor Relations and Corporate Communications at Millennium Pharmaceuticals.